AXGN AxoGen, Inc.

AxoGen Inc is a medical technology company dedicated to peripheral nerve repair. It provide products and education to improve surgical treatment algorithms for peripheral nerve injuries.

$12.25  +0.97 (8.60%)
As of 09/28/2022 15:59:59 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  01/02/2003
Outstanding shares:  42,283,715
Average volume:  249,551
Market cap:   $465,966,539
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B7254K9
Valuation   (See tab for details)
PE ratio:   -14.28
PB ratio:   4.34
PS ratio:   3.66
Return on equity:   -30.62%
Net income %:   -24.97%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy